News

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.

MUSC scientists report successful Alaskan expedition for novel therapeutics for pancreatic cancer.

A newly approved targeted therapy for small cell lung cancer is at the forefront of a new type of drug for solid tumors.

Hollings was part of an international clinical trial that led to the FDA approval of a new drug to treat certain types of gliomas.

Two Hollings researchers are working together to develop a new way to get depression treatment to people with likely incurable cancer.

A new study aims to get a better understanding of what dual use of vapes and cigarettes looks like in real world usage.

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

The MUSC Hollings Cancer Center white coat ceremony inspires HBCU students to pursue research careers.

A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer.